Page last updated: 2024-12-08

alanopine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

alanopine: imino acid produced by a dehydrogenase found in the adductor muscle of the oyster, Crassostrea gigas; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,2'-iminodipropanoic acid : An amino dicarboxylic acid that is 2,2'-iminodiacetic acid substituted by methyl groups at positions 2 and 2'. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439943
CHEBI ID857
SCHEMBL ID109878
MeSH IDM0085969

Synonyms (20)

Synonym
CHEBI:857
2,2'-azanediyldipropanoic acid
2,2'-iminodipropanoic acid
C03210
alanopine
73890-66-1
2,2'-iminodipropionic acid
AKOS014776823
2-[(1-carboxyethyl)amino]propanoic acid
l-alanine, n-(1-carboxyethyl)- (9ci)
219755-19-8
SCHEMBL109878
(+/-)-form
(+/-)-2,2'-iminobispropanoic acid
n-(1-carboxyethyl)-l-alanine
2,2'-iminobispropanoic acid
CS-0239586
EN300-2156815
Q27105373
alanine, n-(1-carboxyethyl)- (9ci)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
amino dicarboxylic acid
amino acid opineAny opine whose structure is based on the condensation of an amino acid with a carbohydrate or a keto-acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (46.15)18.7374
1990's2 (15.38)18.2507
2000's2 (15.38)29.6817
2010's3 (23.08)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]